3,3′,4,4′,5-penta chlorobiphenyl | 22.4 | Concentration (ng/g of lipid)† | | 9.1 (6.7–20.6) | |
Cases/n | 33/208 | 11/69 | |
Prevalence (%) | 15.9 | 15.9 | |
Adjusted* OR (95% CI) | Referent | 1.26 (0.47 to 3.32) | 0.62 |
| | | | | |
1,2,3,4,6,7,8-hepta chlorodibenzo-p-dioxin | 30.5 | Concentration (pg/g of lipid)† | | 38.9 (30.2–50.9) | |
Cases/n | 24/191 | 20/86 | |
Prevalence (%) | 12.6 | 23.3 | |
Adjusted* OR (95% CI) | Referent | 2.08 (1.17 to 3.68) | 0.02 |
| | | | | |
1,2,3,4,6,7,8,9-octa chlorodibenzo-p-dioxin | 26.8 | Concentration (pg/g of lipid)† | | 23.0 (18.5–30.2) | |
Cases/n | 24/199 | 20/78 | |
Prevalence (%) | 12.1 | 25.6 | |
Adjusted* OR (95% CI) | Referent | 2.72 (1.24 to 5.99) | 0.02 |
| | | | | |
1,2,3,4,6,7,8-hepta chlorodibenzofuran | 31.9 | Concentration (pg/g of lipid)† | | 10.0 (7.8–14.8) | |
Cases/n | 23/189 | 21/88 | |
Prevalence (%) | 12.2 | 23.9 | |
Adjusted* OR (95% CI) | Referent | 2.18 (1.15 to 4.15) | 0.02 |
| | | | | |
β-hexachlorocyclo-hexane | 22.4 | Concentration (ng/g of lipid)† | | 17.9 (14.6–26.4) | |
Cases/n | 38/201 | 6/76 | |
Prevalence (%) | 18.9 | 7.9 | |
Adjusted* OR (95% CI) | Referent | 0.37 (0.13 to 1.02) | 0.05 |
| | | | | |
Trans-nonachlor | 25.4 | Concentration (ng/g of lipid)† | | 10.9 (8.4–16.0) | |
Cases/n | 27/207 | 17/70 | |
Prevalence (%) | 13.0 | 24.3 | |
Adjusted* OR (95% CI) | Referent | 1.67 (0.46 to 6.14) | 0.41 |
| | | | | |
| | | Detectable<50th | Detectable⩾50th | |
| | | | | |
p,p′-dichlorodiphenyl trichloroethane | 100 | Concentration (ng/g of lipid)† | 75.3 (49.0–98.4) | 278 (186–528) | |
| Cases/n | 26/138 | 18/139 | |
| Prevalence (%) | 18.8 | 13.0 | |
| Adjusted* OR (95% CI) | Referent | 0.89 (0.24 to 3.37) | 0.85 |